The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Marla C. Dubinsky

Department of Pediatrics

IBD Center

Cedars Sinai Medical Center

Los Angeles

USA

[email]@csmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pediatrics, IBD Center, Cedars Sinai Medical Center, Los Angeles, USA. 2001 - 2009
  • Pediatric IBD Center, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California-Los Angeles, USA. 2008
  • Division of Gastroenterology and Genetics, Department of Medicine and Pediatrics, Cedars-Sinai Medical Center, UCLA, Los Angeles, USA. 2002

References

  1. What is the role of serological markers in IBD? Pediatric and adult data. Dubinsky, M. Dig. Dis (2009) [Pubmed]
  2. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Dubinsky, M.C., Kugathasan, S., Mei, L., Picornell, Y., Nebel, J., Wrobel, I., Quiros, A., Silber, G., Wahbeh, G., Katzir, L., Vasiliauskas, E., Bahar, R., Otley, A., Mack, D., Evans, J., Rosh, J., Hemker, M.O., Leleiko, N., Crandall, W., Langton, C., Landers, C., Taylor, K.D., Targan, S.R., Rotter, J.I., Markowitz, J., Hyams, J. Clin. Gastroenterol. Hepatol. (2008) [Pubmed]
  3. Special issues in pediatric inflammatory bowel disease. Dubinsky, M. World J. Gastroenterol. (2008) [Pubmed]
  4. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Dubinsky, M.C., Wang, D., Picornell, Y., Wrobel, I., Katzir, L., Quiros, A., Dutridge, D., Wahbeh, G., Silber, G., Bahar, R., Mengesha, E., Targan, S.R., Taylor, K.D., Rotter, J.I. Inflamm. Bowel Dis. (2007) [Pubmed]
  5. Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes. Dubinsky, M.C., Fleshner, P.P. Curr. Treat. Options. Gastroenterol (2003) [Pubmed]
  6. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Dubinsky, M.C., Vasiliauskas, E.A., Singh, H., Abreu, M.T., Papadakis, K.A., Tran, T., Martin, P., Vierling, J.M., Geller, S.A., Targan, S.R., Poordad, F.F. Gastroenterology (2003) [Pubmed]
  7. Optimizing immunomodulator therapy for inflammatory bowel disease. Dubinsky, M.C. Curr. Gastroenterol. Rep (2003) [Pubmed]
  8. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Dubinsky, M.C., Yang, H., Hassard, P.V., Seidman, E.G., Kam, L.Y., Abreu, M.T., Targan, S.R., Vasiliauskas, E.A. Gastroenterology (2002) [Pubmed]
  9. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy. Dubinsky, M.C., Hassard, P.V., Seidman, E.G., Kam, L.Y., Abreu, M.T., Targan, S.R., Vasiliauskas, E.A. Inflamm. Bowel Dis. (2001) [Pubmed]
 
WikiGenes - Universities